Results 31 to 40 of about 1,274,523 (300)

Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy. [PDF]

PLoS ONE, 2014
BACKGROUND:HIV patients on suppressive antiretroviral therapy have undetectable viremia making it impossible to screen plasma HIV tropism if regimen change is required during suppression.
Guinevere Q Lee, Winnie Dong, Theresa Mo, David J H F Knapp, Chanson J Brumme, Conan K Woods, Steve Kanters, Benita Yip, P Richard Harrigan   +8 more
doaj   +1 more source

The Association of Clinical Follow-Up Intervals in HIV-Infected Persons with Viral Suppression on Subsequent Viral Suppression [PDF]

AIDS Patient Care and STDs, 2013
The recommendation for the frequency for routine clinical monitoring of persons with well-controlled HIV infection is based on evidence that relies on observed rather than intended follow-up intervals. We sought to determine if the scheduled follow-up interval is associated with subsequent virologic failure.
April, Buscher, Michael, Mugavero, Andrew O, Westfall, Jeanne, Keruly, Richard, Moore, Mari-Lynn, Drainoni, Meg, Sullivan, Tracey E, Wilson, Allan, Rodriguez, Lisa, Metsch, Lytt, Gardner, Gary, Marks, Faye, Malitz, Thomas P, Giordano   +13 more
openaire   +2 more sources

HIV viral suppression in the era of antiretroviral therapy [PDF]

Postgraduate Medical Journal, 2003
Abstract Altogether 42 million people worldwide have been infected with HIV, and 12 million have died over the last 20 years. Effective antiretroviral therapy has lead to sustained HIV viral suppression and immunological recovery in patients who have been infected with the virus.
H K, Thaker, M H, Snow
openaire   +2 more sources

Viral suppression and associated factors among children tested for HIV viral load at Amhara Public Health Institute, Dessie Branch, Ethiopia: a cross-sectional study

BMJ Open, 2023
Objective This study aims to assess viral suppression and associated factors among children tested for HIV viral load at the Amhara Public Health Institute, Dessie Branch, Ethiopia.Design An institutional cross-sectional study was conducted.
Hailu Berihun, Getaw Walle Bazie, Altaseb Beyene, Amare Zewdie, Natnael Kebede   +4 more
doaj   +1 more source

Suppression of HBV by Tenofovir in HBV/HIV coinfected patients : a systematic review and meta-analysis [PDF]

, 2013
Background: Hepatitis B coinfection is common in HIV-positive individuals and as antiretroviral therapy has made death due to AIDS less common, hepatitis has become increasingly important. Several drugs are available to treat hepatitis B. The most potent
Thomas Reiberger, Richard Gilson, Noriyoshi Kuzushita, Firouze Bani-Sadr (432319), Nüesch, R, David Dunn (37023), Marina Núñez, Lionel Tan, Stephan Christoph, Peters, M, Tan, L (Lionel), Pillay, Deenan, Huw Price, de Vries-Sluijs, T, Reto Nüesch, Dunn, David, Peters, Marion, Kuzushita, N, Kuzushita Noriyoshi, Firouze Bani-Sadr, Bani-Sadr, Firouze, Mauss Stefan, Reiberger, Thomas, Stefan Mauss, Gilson, Richard, Mauß, Stefan, Mamta K Jain, Theodora de Vries-Sluijs, Tan, Lionel, Gilson, R, Price, H, Gilson Richard, Huw Price (300124), Jain Mamta K., Peters Marion, Reiberger Thomas, Thomas Reiberger (143056), Nüesch Reto, Price, Huw, Richard Gilson (125405), David Dunn, Reto Nüesch (432324), Nüesch, Reto, Marina Núñez (432323), Pillay Deenan, Deenan Pillay (7888), Price Huw, Tan, L, Tan Lionel, Dunn David, Kuzushita, Noriyoshi, Christoph Stephan (283267), Stephan, C, Christoph Stephan, Pillay, D, Núñez Marina, Núñez, M, Stefan Mauss (143062), Bani-Sadr, F, Peters, M (Marjolein), Jain, MK, Bani-Sadr Firouze, de Vries-Sluijs Theodora, Stephan, Christoph, Theodora de Vries-Sluijs (432320), Lionel Tan (124548), Dunn, D, Marion Peters, Reiberger, T, Mamta K. Jain, Noriyoshi Kuzushita (432322), Mamta K. Jain (432321), Marion Peters (403490), Mauss, S, Jain, Mamta K., Núñez, Marina, Deenan Pillay, Nueesch, R, Vries-Sluijs, Theodora de, Peters, M.G. (Marion), Núñez, M.J. (Marina), Pillay, D. (Deenan), Nüesch, E. (Eveline), Tan, L. (Lionel), Price, H. (Huw), Mauss, S. (Stefan), Gilson, E. (Eric), Dunn, D. (David), Jain, A. (Ashok), Vriessluijs, T.E.M.S. (Theodora) de, Bani-Sadr, F. (Firouze), Stephan, C. (Carsten), Kuzushita, N. (Noriyoshi), Reiberger, T. (Thomas)   +93 more
core   +2 more sources

Impact of a Revised Ryan White Part A HIV Care Coordination Program on Viral Suppression and Durable Viral Suppression. [PDF]

J Acquir Immune Defic Syndr
Background: In 2018, the New York City Health Department implemented a revised care coordination program (CCR) to facilitate delivery and strengthen the impact of an already effective intervention among people with HIV (PWH) struggling with viral suppression (VS).
Avoundjian T, Robertson MM, Abdelqader F, Braunstein SL, Nash D, Irvine MK.   +5 more
europepmc   +3 more sources

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity [PDF]

, 2011
Cellular immune responses during acute Hepatitis C virus (HCV) and HIV infection are a known correlate of infection outcome. Viral adaptation to these responses via mutation(s) within CD8+ T-cell epitopes allows these viruses to subvert host immune ...
Paul Klenerman, Malte Heeg, John, Mina, Pfafferott, K, James, Ian, Ulsenheimer, Axel, Helmut M. Diepolder, Lucas, A.D., Silvana Gaudieri, Heeg, M, Rauch, A, Ian James, John, M., Andri Rauch, Klenerman, P., James, I, Simon Mallal, Diepolder, HM, Heeg, Malte, John, M, Mallal, Simon, Lucas, Andrew, Nolan, D., Lucas, M., Heeg, M., Michaela Lucas, Diepolder, H.M., Mallal, S., Gaudieri, S, Lucas, M, Gaudieri, S., Nolan, David, Ulsenheimer, A, Lucas, A, David Nolan, Klenerman, Paul, Diepolder, Helmut M., Pfafferott, K., Klenerman, P, Rauch, A., Ulsenheimer, A., Pfafferott, Katja, Lucas, Michaela, Katja Pfafferott, Andrew Lucas, Rauch, Andri, Diepolder, Helmut M, Axel Ulsenheimer, Mina John, Helmut M Diepolder, Nolan, D, Mallal, S, James, I., Gaudieri, Silvana   +53 more
core   +3 more sources

Viral interferon antagonists and antiviral drugs [PDF]

, 2009
For this project, we developed reporter cell lines that express viral proteins with the potential to be used in cell-based screening assays to select chemical candidates for antiviral drugs.
Nobre, Rita
core   +2 more sources

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

BMC Women's Health, 2020
Background Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills for some people living with HIV ...
Lorie Benning, Andrea Mantsios, Deanna Kerrigan, Jenell S. Coleman, Elizabeth Golub, Oni Blackstock, Deborah Konkle-Parker, Morgan Philbin, Anandi Sheth, Adaora A. Adimora, Mardge H. Cohen, Dominika Seidman, Joel Milam, Seble G. Kassaye, Tonya Taylor, Miranda Murray   +15 more
doaj   +1 more source

Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study

AIDS Research and Therapy, 2021
Background When considering adherence to antiretroviral therapy (ART) for HIV, many different cut-points are used. The primary goals of this study were to identify a level of self-reported medication adherence that best distinguished HIV viral ...
Emma O’Halloran Leach, Huiyin Lu, Joshua Caballero, Jennifer E. Thomas, Emma C. Spencer, Robert L. Cook   +5 more
doaj   +1 more source